Levocetirizine Hydrochloride Tablets
Function and Efficacy
This product is an oral selective histamine H1 receptor antagonist. It has no obvious anticholinergic and anti-5-hydroxytryptamine effects, and has a small central inhibitory effect.
Ingredients
The main ingredient of this product is levocetirizine hydrochloride.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Levocetirizine dihydrochlorideIngredients |
This product is an oral selective histamine H1 receptor antagonist. It has no obvious anticholinergic and anti-5-hydroxytryptamine effects, and has a small central inhibitory effect. More |
130018-87-0 | 22 |
Appearance
This product is off-white tablets.
Indication
Usage and Dosage
Oral administration: Adults and children over 6 years old, 1 tablet once a day. Children aged 2-6 years old, 1/2 tablet once a day.
Adverse Reactions
This product is well tolerated, with mild adverse reactions that can mostly heal on their own. Common adverse reactions include drowsiness, dry mouth, headache, fatigue, etc.
Precautions
It is contraindicated for those who are allergic to this product and other excipients.
Special Population Medication
Precautions for children: The safety of the drug for children under 2 years old has not been determined. Precautions for pregnancy and lactation: This product is contraindicated for pregnant and lactating women. Precautions for the elderly: The physiological functions of the elderly usually decline, so this product should be used with caution.
Drug Interactions
There are no drug interaction studies using this product. Racemic cetirizine has no interaction with pseudoephedrine, cimetidine, ketoconazole, erythromycin, azithromycin, glipizide, and diazepam.
Storage
Keep in a light-proof, sealed, dry place.
Packaging Specification
5 mg
Validity Period
24 months
Manufacturer
Chongqing Huapont Pharmaceutical Co., Ltd.
-
Founded in:
2012-06-26 -
Address:
No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing -
Tax NO.:
915000005992299001 -
Registered Funds:
450 million yuan -
Website:
-
Email: